Movember Prostate Cancer UK Major Awards in Curative Treatments

Major Awards in Curative Treatment

Following on from the success of last year’s Major Awards funding call into curative treatments, we are launching a second round of this strategic initiative. This call is now open for applications!

We believe men deserve better. They deserve a future where they don’t have to fear being harmed by treatments or having their cancer return. They deserve a future where their lives and bodies are not harmed by prostate cancer.

We want to fund research that can improve the outcomes for men treated in the curative setting. This can be research that helps men select the most appropriate treatment for them, research aimed at increasing the effectiveness of initial treatment in terms of cancer control, or research focused on reducing side effects from initial treatment, without reducing cancer control.

This call has now closed

Further details about this scheme can be found in our Guidance Notes

The deadline for submissions was 2 August 2021

Remit & Eligibility

The focus of this call is to support clinical (or translational) research to improve initial treatment with curative intent, either through greater precision of treatment modalities or through better informed treatment decisions which will result in the best outcomes for that individual. Through this call we aim to support research into the treatment of localised disease as well as research aimed at curing locoregional disease (for example, T3/T4 disease and/or true N1 M0 disease). Research into the treatment of oligometastatic/metastatic disease, or biochemical recurrence, are not in the scope of this call.

Through this call we will support:

  1. Clinical trials in the research areas highlighted below.
  2. Translational research that will lead to commencement of clinical work either towards the end of the project or as the immediate next step following completion of the grant (projects must be able to articulate a clear pathway to impact and have a good idea of the subsequent clinical trial).
  3. Research using patient samples/data/images from existing clinical trials to address any of the research themes highlighted below.

Full details of eligibility and the research themes we would like to see are included in the accompanying Guidance Document.

Application process

DEADLINE: Applicants must submit their proposals and ensure that all online declarations and approvals have been completed by the relevant parties before 12pm (noon) on 2 August 2021.

PEER REVIEW: Submitted applications will then be subject to external peer review. The peer reviewers' comments will be sent to the applicants (anonymously) in October 2021 via our online system. Applicants will have an opportunity to submit a response to the reviewers' comments.

DECISION: All applications, reviews and rebuttals will then be considered by our Research Advisory Committee who shall make final funding recommendations to our Board of Trustees.

NOTIFICATION: Final funding decisions will be in December 2021 and applicants will be notified as to the outcome of their submission via email shortly afterwards. We appreciate your patience during this time.

All awards will be made in accordance with our standard grant terms and conditions.

Last year we received 11 proposals to this scheme, with a success rate of 45%.

Contact us

If you have any questions or would like to discuss an application with the Research Team, please email [email protected].